Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 361 - 380 of 467
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2012, 3:33 am
It also noted that Philipson’s research was supported in part by Bristol-Myers Squibb Co. [read post]
25 Mar 2021, 11:33 am by Dennis Crouch
With Specific Jurisdiction, the Court’s recent decision in Bristol-Myers Squibb Co. v. [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
15 Jul 2019, 12:55 pm by Adam Levitin
  There may have been a link between silicone implants (particularly ruptured ones) and auto-immune problems, and by the early 1990s, lawsuits were piling up against manufacturers of silicone implants, including Dow Corning, Baxter, and Bristol-Myers Squibb. [read post]
17 Jul 2009, 2:29 pm
(Lynnfield, MA; Constantine Kalogianis, President) Adnexus, A Bristol-Myers Squibb R&D Company (Waltham, MA; Sonia Vora, President) Advanced Beauty Corporation (Braintree, MA; Hanna Le, President) Advanced Integrated Solutions Corp. [read post]
17 Jan 2007, 8:11 am
Other large companies that recently instituted or announced plans to adopt majority voting include Humana, Qwest Communications, AT&T, Bristol-Myers Squibb, Lexmark, Cummins, and McKesson, according to news reports. [read post]
15 Dec 2008, 2:00 pm
Shortly after the drug hit the market, Sanofi-Synthelabo, which owns the Plavix patent, and Bristol-Myers Squibb, owner of the Plavix marketing rights, sought and obtained an injunction barring sales of the generic. [read post]
31 Jan 2009, 6:54 am
• Bristol-Myers Squibb posted a quarterly profit of $1.24 billion. [read post]
23 Jun 2011, 6:33 pm by Frank Pasquale
AstraZeneca marketed Seroquel off-label for children and the elderly (another vulnerable population, often administered antipsychotics in nursing homes); Pfizer faced similar charges for Geodon (an antipsychotic); Eli Lilly for Zyprexa (an antipsychotic); Bristol-Myers Squibb for Abilify (another antipsychotic); and Forest Labs for Celexa (an antidepressant). [read post]
16 Feb 2010, 4:31 am by Broc Romanek
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
20 Mar 2023, 7:52 am by Rebecca Tushnet
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Seedlings Life Science Ventures, LLC (Seedlings) is an early-stage health-care research and product development company. [read post]
3 Apr 2007, 9:04 am
Merck successfully challenged the proposal on grounds that it is substantially the same as a 2005 resolution focused more narrowly on animal testing, which had gotten less than the 3 percent support needed for resubmission, and when Bristol-Myers Squibb filed a similar challenge, PETA withdrew the proposal there. [read post]
11 Mar 2019, 10:15 am by Scott Sternberg
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019) followed suit and unanimously affirmed snap removal as a procedural vehicle to remove to federal court. [read post]
18 Jan 2009, 4:48 pm
Dasatinib is an anti-cancer drug belonging to the class of tyrosine kinase inhibitors first approved in the United States on June 28, 2006 and marketed by Bristol-Myer Squibb (BMS) under the brand name Sprycel. [read post]
16 Jun 2011, 10:59 am by editor
Yet, Edward Osei, an assistant professor of law at Widener University, who also formerly worked at AstraZeneca and Bristol Myers Squibb, said that although one product is injectable and the other is oral, this still may pose a concern under the agreement because both products serve the same patient population with the same prescribing physicians. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]